has received honoraria and/or paid consultancy from Abbott Nutrition, Nutricia, Nestl Health Science, Fresenius Kabi and Pfizer
Benefits of IV Drip Therapy Over Oral Supplements Ingestion Many people wonder why they should use IV drip therapy instead of typical orally consumed vitamins or supplements
The North America GLP-1 receptor agonist market size is estimated at USD 13.8 billion in 2025 and is projected to reach approximately USD 38.4 billion by 2035, with a 10.8% CAGR from 2026 to 2035
The four components span distinct structural classes and non-overlapping pathway layers signaling, ECM remodeling, cytoskeleton, and inflammation
Advanced glycation end products (AGEs) are heterogeneous molecules that are obviously elevated in diabetes, renal failure, and aging due to non-enzymatic protein glycation
Future research should aim to clarify the mechanisms underpinning potential interactions, quantify the risks, and explore the efficacy of alternative pain management strategies in this patient population